Karuna

Do Karuna, Cerevel Deals Signal Renewed Neuropsychiatric Interest From Big Pharma?
BioSpace
Mon, 06/3/24 - 12:09 pm
Karuna
Cerevel Therapeutics
neuropsychiatric
FDA kicks off review of Karuna’s schizophrenia drug KarXT
Pharmaphorum
Wed, 11/29/23 - 11:57 am
Karuna
KarXT
FDA
schizophrenia
Karuna’s schizophrenia drug succeeds in a second late-stage trial
BioPharma Dive
Mon, 03/20/23 - 09:53 am
Karuna
clinical trials
schizophrenia
KarXT
Karuna's 'A-ha moment': A billion-dollar stock swing and new expectations
Biopharma Dive
Tue, 11/26/19 - 11:41 pm
Karuna
schizophrenia
KarXT
Back to business for biotech flotations
EP Vantage
Wed, 07/3/19 - 09:48 am
IPOs
BridgeBio
Turning Point Therapeutics
Stoke Therapeutics
Prevail Therapeutics
Atreca
NGM Biopharmaceuticals
Akero Therapeutics
Milestone Pharmaceuticals
Morphic Therapeutics
Karuna
Puretech-backed Karuna makes Nasdaq debut with $89M IPO
Endpoints
Sat, 06/29/19 - 02:31 pm
Karuna
IPOs
NASDAQ
PureTech
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 06/23/19 - 02:04 pm
Merck
Keytruda
Melinta Therapeutics
Amag Pharmaceuticals
Palatin
Acer Therapeutics
Sanofi
Regeneron
Alexion
Pfizer
Roche
Navidea Biopharmaceuticals
Ascendis Pharma
Scholar Rock
Adaptive Biotechnologies
BridgeBio
IPOs
G Medical Innovations
Karuna
Morphic Therapeutics
Karuna Therapeutics Raises Its IPO Estimate to $85 Million
Mon, 06/17/19 - 09:24 am
Karuna
schizophrenia
Alzheimer's disease
Schizophrenia therapy developer Karuna seeking IPO
BioCentury
Fri, 04/26/19 - 11:37 am
IPOs
Karuna
antipsychotics
schizophrenia
Karuna looks past schizophrenia with $68M series B
BioCentury
Mon, 03/18/19 - 10:37 am
Karuna
KarXT
schizophrenia
geriatric psychosis
pain